Global Botanical And Plant-Derived Drugs Market 2024-2028
The botanical and plant-derived drugs market is forecasted to grow by USD 20.93 bn during 2023-2028, accelerating at a CAGR of 8.18% during the forecast period. The report on the botanical and plant-derived drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising government initiatives to promote the use of plant-derived drugs, limitations associated with conventional drugs, and growing demand for effective treatment of chronic disorders.
Technavio's botanical and plant-derived drugs market is segmented as below:
By Type
By Application
- Infectious diseases
- Central nervous system
- Cardiovascular diseases
- Respiratory diseases
- Digestive diseases and others
By Geographical Landscape
- Asia
- Europe
- North America
- Rest of World (ROW)
This study identifies the transformation of the regulatory landscape in US as one of the prime reasons driving the botanical and plant-derived drugs market growth during the next few years. Also, the growing focus on the development of drugs for new medical fields and the emergence of new entrants with innovative products will lead to sizable demand in the market.
The report on the botanical and plant-derived drugs market covers the following areas:
- Botanical and plant-derived drugs market sizing
- Botanical and plant-derived drugs market forecast
- Botanical and plant-derived drugs market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading botanical and plant-derived drugs market vendors that include Bausch Health Companies Inc., Bayer AG, Boehringer Ingelheim International GmbH, Devonian Health Group Inc., Dr. Willmar Schwabe GmbH and Co. KG, F. Hoffmann La Roche Ltd., Hetero Labs Ltd., Jaguar Health Inc., Jazz Pharmaceuticals Plc, Medigene AG, Merck KGaA, Novartis AG, Pfizer Inc., Pierre Fabre SA, Protalix Biotherapeutics Inc., Riaan Wellness Pvt. Ltd., Wilson Drugs and Pharmaceuticals Pvt. Ltd., Zea Biosciences Corp, Sanofi SA, Sun Pharmaceutical Industries Ltd., and Vertex Pharmaceuticals Inc. Also, the botanical and plant-derived drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.